Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Renal Artery Stenting in Consecutive High-Risk Patients With Atherosclerotic Renovascular Disease: A Prospective 2-Center Cohort Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Cause-Specific Mortality in Patients During Long-Term Follow-Up After Atrial Switch for Transposition of the Great Arteries

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Altered Cerebral Microstructure in Adults With Atrial Septal Defect and Ventricular Septal Defect Repaired in Childhood

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association of Common and Rare Genetic Variation in the 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Gene and Cataract Risk

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Microcirculatory Function in Nonhypertrophic and Hypertrophic Myocardium in Patients With Aortic Valve Stenosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Mark Reinhard
  • Karoline Schousboe
  • Ulrik B Andersen
  • Niels Henrik Buus
  • Jesper Moesgaard Rantanen
  • Jesper Nørgaard Bech
  • Hossein Mohit Mafi
  • Sten Langfeldt
  • Arindam Bharadwaz
  • Arne Hørlyck
  • Mogens Kærsgaard Jensen
  • Jørgen Jeppesen
  • Michael Hecht Olsen
  • Ib Abildgaard Jacobsen
  • Bo Martin Bibby
  • Kent Lodberg Christensen
Vis graf over relationer

Background The aim of this study was to prospectively evaluate the effects of renal artery stenting in consecutive patients with severe atherosclerotic renal artery stenosis and high-risk clinical presentations as defined in a national protocol developed in 2015. Methods and Results Since the protocol was initiated, 102 patients have been referred for revascularization according to the following high-risk criteria: severe renal artery stenosis (≥70%) with true resistant hypertension, rapidly declining kidney function, or recurrent heart failure/sudden pulmonary edema. At baseline, the mean 24-hour ambulatory systolic blood pressure was 166.2 mm Hg (95% CI, 162.0-170.4), the defined daily dose of antihypertensive medication was 6.5 (95% CI, 5.8-7.3), and the estimated glomerular filtration rate was 41.1 mL/min per 1.73m2 (95% CI, 36.6-45.6). In 96 patients with available 3-month follow-up data, mean 24-hour ambulatory systolic blood pressure decreased by 19.6 mm Hg (95% CI, 15.4-23.8; P<0.001), the defined daily dose of antihypertensive medication was reduced by 52% (95% CI, 41%-62%; P<0.001), and estimated glomerular filtration rate increased by 7.8 mL/min per 1.73m2 (95% CI, 4.5-11.1; P<0.001). All changes persisted after 24 month follow-up. Among 17 patients with a history of hospitalization for acute decompensated heart failure, 14 patients had no new episodes after successful revascularization. Conclusions In this prospective cohort study, we observed a reduction in blood pressure and antihypertensive medication, an increase in estimated glomerular filtration rate, and a decrease in new hospital admissions attributable to heart failure/sudden pulmonary edema after renal artery stenting. Registration URL: https://clinicaltrials.gov. Identifier: NCT02770066.

OriginalsprogEngelsk
Artikelnummere024421
TidsskriftJournal of the American Heart Association
Vol/bind11
Udgave nummer7
Sider (fra-til)1-20
Antal sider20
ISSN2047-9980
DOI
StatusUdgivet - 5 apr. 2022

ID: 75790402